Repurposing cadazolid as a CBLB-dependent non-PROTAC FAK degrader to suppress lung adenocarcinoma and restore EGFR-TKI sensitivity

Energy and Built Environment · Elsevier

Аннотация

Publication date: Available online 17 November 2026 Source: Journal of Pharmaceutical Analysis Author(s): Yihua Zhang, Yuna Shao, Liying Zhang, Shihang Ren, Di Lu, Huiling Zhang, Xinyu Qian, Yuling Chen, Yang Yang, Jianjie Zhu, Yuanyuan Zeng, Shengjie Wang, Zhaowei Yan, Zeyi Liu

Читать у издателя →

Похожие статьи